Inventor

ZHANG TINGHU

US53 patents

⚠️ This page may combine multiple inventors who share the name “ZHANG TINGHU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHANG TINGHU

DANA FARBER CANCER INST INC

Inhibitors of cyclin-dependent kinases

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of c-Jun-N-terminal kinase (JNK)

Inhibitors of c-Jun-N-terminal kinase (JNK)

Inhibitors of cyclin-dependent kinases

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Tricyclic kinase inhibitors of MELK and methods of use

Inhibitors of cyclin-dependent kinases

Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

Inhibitors of c-Jun-N-terminal kinase (JNK)

Inhibitors of cyclin-dependent kinase 7 (CDK7)

4,6-pyrimidinylene derivatives and uses thereof

Fused bicyclic pyrimidine derivatives and uses thereof

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

Ligands to cereblon (CRBN)

Inhibitors of cyclin-dependent kinases

Sulfonamide derivatives for protein degradation

Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use

Heterobifunctional compounds with improved specificity

Inhibitors of cyclin-dependent kinases

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of cyclin-dependent kinase 7 and uses thereof

Small molecule degraders of polybromo-1 (PBRM1)

Ligands to cereblon (CRBN)

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use

Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK

Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders

Sulfonamide derivatives for protein degradation

NEK inhibitors and methods of use

Inhibitors of interleukin-1 receptor-associated kinases and uses thereof

Salicylate inhibitors of MELK and methods of use

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK

Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereof

Small molecule degraders of Helios and methods of use

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use

Immunomodulatory compounds

Bispecific degraders

CRBN modulators

CDK2/5 degraders and uses thereof

Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof

Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof

Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof

Degraders that target proteins via KEAP1

ISOCURE BIOSCIENCES INC

Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof

Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof

SYROS PHARMACEUTICALS INC

Heteroaromatic compounds useful for the treatment of proliferative diseases